Clinical Trial Update: A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases [Phase 3]

View source ↗

Summary

A Phase 3 study by Boehringer Ingelheim is testing nerandomilast for interstitial lung disease related to systemic autoimmune rheumatic diseases; recruitment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Systemic Autoimmune Rheumatic Disease-associated Interstitial Lung Disease

Drugs mentioned

• Nerandomilast

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases | Phase 3 | Status: RECRUITING